Ameritas Investment Partners
CRMD icon

Ameritas Investment Partners’s CorMedix CRMD Stock Holding History

Ameritas Investment Partners’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51.5K Hold
6,562
– – ﹤0.01% 2240
2026
Q1 		$44.6K Hold
6,562
– – ﹤0.01% 2151
2025
Q4 		$76.3K Hold
6,562
– – ﹤0.01% 1856
2025
Q3 		$76.3K Hold
6,562
– – ﹤0.01% 1853
2025
Q2 		$80.8K Buy
6,562
+998
+18% +$11K ﹤0.01% 1897
2025
Q1 		$34.3K Hold
5,564
– – ﹤0.01% 2312
2024
Q4 		$45.1K Hold
5,564
– – ﹤0.01% 2249
2024
Q3 		$45K Buy
5,564
+1,879
+51% +$10.2K ﹤0.01% 2259
2024
Q2 		$16K Hold
3,685
– – ﹤0.01% 2714
2024
Q1 		$15.6K Hold
3,685
– – ﹤0.01% 2667
2023
Q4 		$13.9K Hold
3,685
– – ﹤0.01% 2735
2023
Q3 		$13.6K Hold
3,685
– – ﹤0.01% 2702
2023
Q2 		$14.6K Buy
+3,685
New +$18.2K ﹤0.01% 2722
2022
Q2 		– Sell
-2,679
Closed -$15K – 3099
2022
Q1 		$15K Hold
2,679
– – ﹤0.01% 2662
2021
Q4 		$12K Hold
2,679
– – ﹤0.01% 2837
2021
Q3 		$12K Hold
2,679
– – ﹤0.01% 2886
2021
Q2 		$18K Hold
2,679
– – ﹤0.01% 2782
2021
Q1 		$27K Buy
2,679
+600
+29% +$6.32K ﹤0.01% 2420
2020
Q4 		$15K Hold
2,079
– – ﹤0.01% 2607
2020
Q3 		$13K Hold
2,079
– – ﹤0.01% 2586
2020
Q2 		$13K Hold
2,079
– – ﹤0.01% 2567
2020
Q1 		$7K Hold
2,079
– – ﹤0.01% 2675
2019
Q4 		$15K Hold
2,079
– – ﹤0.01% 2547
2019
Q3 		$13K Hold
2,079
– – ﹤0.01% 2606
2019
Q2 		$19K Buy
+2,079
New +$16.3K ﹤0.01% 2462

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Ameritas Investment Partners's CRMD Position: Q2 2026 in Review

Ameritas Investment Partners held its CorMedix (CRMD) position steady in Q2 2026 at 6,562 shares worth $51.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Ameritas Investment Partners first reported a position in CRMD in Q2 2019 and has held it in 25 quarters since. The position peaked at $80.8K in Q2 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Ameritas Investment Partners held 6,562 shares of CorMedix worth $51.5K as of Q2 2026.
  • Ameritas Investment Partners left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2240 holding.
  • Ameritas Investment Partners first reported a position in CorMedix in Q2 2019 and has held it in 25 quarters since.
  • Ameritas Investment Partners's CorMedix position peaked at $80.8K in Q2 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.